Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases

by Valeria Nucera, Elisabetta Gerratana, Manuela Giallanza, Laura La Corte, Donatella Sangari
Published 2021-01-01

Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications

by Gian Luca Erre, Marco Sebastiani, Andreina Manfredi, Elisabetta Gerratana, Fabiola Atzeni, Giuseppe Passiu, Arduino A Mangoni
Published 2021-01-01

Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs?

by Fabiola Atzeni, Elisabetta Gerratana, Ignazio Francesco Masala, Sara Bongiovanni, Piercarlo Sarzi-Puttini, Javier Rodríguez-Carrio, Javier Rodríguez-Carrio
Published 2021-08-01

Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides?

by Giovanni Adami, Elisabetta Gerratana, Fabiola Atzeni, Camilla Benini, Elisabetta Vantaggiato, Denise Rotta, Luca Idolazzi, Maurizio Rossini, Davide Gatti, Angelo Fassio
Published 2021-02-01

The Rheumatology Drugs for COVID-19 Management: Which and When?

by Fabiola Atzeni, Ignazio Francesco Masala, Javier Rodríguez-Carrio, Roberto Ríos-Garcés, Elisabetta Gerratana, Laura La Corte, Manuela Giallanza, Valeria Nucera, Agostino Riva, Gerard Espinosa, Ricard Cervera
Published 2021-02-01

Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study

by Maria Antonietta Barbieri, Giuseppe Cicala, Paola Maria Cutroneo, Elisabetta Gerratana, Caterina Palleria, Caterina De Sarro, Ada Vero, Luigi Iannone, Antonia Manti, Emilio Russo, Giovambattista De Sarro, Fabiola Atzeni, Edoardo Spina
Published 2020-04-01